Skip to content

Clinical trials

Scleroderma, Systemic trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Country / region: Israel Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20131
20143
20151
20161
20181
20192
20222
20233
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting5
Terminated4
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim3
Echosense Ltd.3
Meir Medical Center3
Actelion1
Amgen1
AstraZeneca1
ChemomAb Ltd.1
EMD Serono Research & Development Institute, Inc.1
Genentech, Inc.1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic19
Scleroderma, Diffuse4
Arthritis, Rheumatoid3
Hypertension, Pulmonary3
Lung Diseases, Interstitial3
Lupus Erythematosus, Systemic3
Autoimmune Diseases2
Myositis2
Antiphospholipid Syndrome1
Cholangitis, Sclerosing1

Trials

Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.